702 filings
Page 6 of 36
8-K
mpqafatrrp
15 Mar 19
Departure of Directors or Certain Officers
5:00pm
8-K
yngr5 7xjeh1j1g
7 Mar 19
Adhera Therapeutics and Alyvant Enter into Digital Co-Promotion Agreement for Prestalia
12:00am
8-K
jto2d7 pkpvhz4x
22 Jan 19
Departure of Directors or Certain Officers
8:30am
8-K
2vvh kcl9x41v
21 Nov 18
Adhera Therapeutics Provides Third Quarter 2018 Financial Results and Business Update
6:15am
NT 10-Q
7j5rqqvt elq9p3bng
15 Nov 18
Notice of late quarterly filing
10:39am
8-K
4wekp2ot7y571o
14 Nov 18
Entry into a Material Definitive Agreement
12:00am
8-K
imvv1mh
25 Oct 18
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
if5cq l6kfc8p0
9 Oct 18
Marina Biotech Announces Name Change to Adhera Therapeutics to More Closely Reflect the Mission of Improving Patient Outcomes
8:30am
8-K
3i2ggg
3 Oct 18
Marina Biotech Appoints Nancy R. Phelan to the Board of Directors
8:30am
8-K
udne5wpmk6igp bh
24 Sep 18
Marina Biotech Appoints Eric Teague as Chief Financial Officer
4:30pm
D
dt4qm
25 Jul 18
$11M in equity / options / securities to be acquired, sold $1.54M, 9 investors
6:15am
8-K
wld91qr q7n6uzy
16 Jul 18
Entry into a Material Definitive Agreement
9:02am
8-K
3zr9ywh3h2gat
29 Jun 18
Marina Biotech Appoints Uli Hacksell, Ph.D. and Robert C. Moscato to Board of Directors
9:30am
8-K
uufoo 55mx8cjzg
20 Jun 18
Marina Biotech Appoints Robert Moscato to Chief Executive Officer
11:40am
8-K
ewk4ww762vtrc 7vqrg
18 May 18
Entry into a Material Definitive Agreement
5:10pm